Speaker illustration

Doctor Juan Du

Shanghai (China)

Member of:

European Society of Cardiology

Clinical outcomes of edoxaban treatment in atrial fibrillation patients with high bleeding risk: insights from the ETNA-AF-China 1-year follow-up

Event: ESC Congress 2024

Topic: Oral Anticoagulation

Session: Oral anticoagulant therapy for atrial fibrillation in clinical practice

Thumbnail